Form 4 for MNKD MANNKIND CORP
Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-10 · accession 0000950170-25-073082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-05-15 | 2025-05-12 | MNKD | Thomson David | EVP Genl Counsel, Sec | F - Tax | $4.56 | -130.8K | 804.6K | -14% | -$596.6K |
| DT | 2025-05-15 | 2025-05-13 | MNKD | Thomson David | EVP Genl Counsel, Sec | S - Sale | $4.68 | -32.2K | 772.4K | -4% | -$150.6K |
| DMT | 2025-05-15 | 2025-05-10+ | MNKD | Thomson David | EVP Genl Counsel, Sec | A - Grant | $0.00 | +224.6K | 891.4K | +34% | $0 |
| DT | 2025-05-15 | 2025-05-13 | MNKD | Thomson David | EVP Genl Counsel, Sec | A - Grant | $0.00 | +145.0K | 145.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 Par Value | 2025-05-12 | F | D | 118,473 | $4.56 | 816,970 | D | — | — | |
| 2 | Common | Common Stock, $0.01 Par Value | 2025-05-12 | F | D | 12,364 | $4.56 | 804,606 | D | — | — | |
| 3 | Common | Common Stock, $0.01 Par Value | 2025-05-13 | S | D | 32,179 | $4.68 | 772,427 | D | — | — | (F4) The weighted average sales price of the reported transaction was $4.68 based on a range of prices between $4.65 and $4.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Common | Common Stock, $0.01 Par Value | 2025-05-10 | A | A | 105,600 | $0.00 | 935,443 | D | — | — | |
| 5 | Common | Common Stock, $0.01 Par Value | 2025-05-13 | A | A | 119,000 | $0.00 | 891,427 | D | — | — | |
| 6 | Derivative | Performance Restricted Stock Unit | 2025-05-13 | A | A | 145,000 | $0.00 | 145,000 | D | — · — to — | 145,000 Common Stock, $0.01 Par Value | (F6) Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. (F7) The performance-based restricted stock unit will vest on July 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2025 until June 30, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. |